San José, Costa Rica, April 2025. SteinCares, a leading specialty healthcare company in Latin America, is expanding its long-standing partnership with Medac GmbH, a global pharmaceutical company based in Germany, to bring Metoject® to four new markets: the Dominican Republic, Panama, Costa Rica, and Guatemala. This expansion builds on Metoject®’s successful
San Jose, Costa Rica, February 2024 – SteinCares, a leading specialty healthcare company in Latin America with a solid footprint in more than 30 countries across the region, announces its official expansion into the Brazilian market, marking a key milestone in its regional growth strategy. Under the leadership of Julio Avella,
Suzhou, China, January 20, 2025 – CStone Pharmaceuticals (“CStone”, HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced a strategic commercialization partnership with SteinCares, a leading pharmaceutical company with over 40 years of experience anda strong presence in Latin America. Under this agreement, SteinCares
San Jose, Costa Rica, January 2025-. SteinCares, a leading specialty healthcare company in Latin America, has announced a commercialization agreement with Molteni Farmaceutici, an Italian company specializing in pain management, to expand access to Oramorph®, a Molteni Farmaceutici proprierty pharma product novel morphine oral solution across the region. The companies will
GUANGZHOU, China and San Jose, Costa Rica – SteinCares, a leading specialty healthcare company in Latin America, and Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced an expansion of their partnership with the addition of a third biosimilar. Under the agreement, SteinCares will have exclusive rights
San Jose, Costa Rica, October 29, 2024 – SteinCares, a leading specialty healthcare company in Latin America, announces a new distribution agreement with Biotest AG, a multinational company specializing in biological therapies derived from human plasma, for the commercialization and distribution of Haemoctin® throughout selected Latin American countries (Chile, Colombia, Costa Rica,
San Jose, Costa Rica, August 2024-. SteinCares, a leading specialty healthcare company in Latin America, announces the acquisition of Laboratorios C&D Pharma in Chile. This strategic transaction consolidates the company’s position in the market and expands its portfolio of pain management and palliative care treatments. The agreement will drive SteinCares’ growth
San Jose, Costa Rica, August 2024 – SteinCares, a leading specialty healthcare company in Latin America, has expanded its exclusive licensing agreement with Pharmacosmos for Monofer® in Colombia. This innovative therapy addresses iron deficiency anemia, a condition that affects 25% of children under the age of 5 and half of pregnant
Guangzhou, China and San José, Costa Rica – Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, and SteinCares, one of Latin America’s leading specialty healthcare companies, announced today a new licensing agreement for two biosimilars under which SteinCares will have exclusive rights to distribute and market Bio-Thera’s pharmaceuticals
San Jose, Costa Rica, September 2023. SteinCares, one of Latin America’s leading specialty healthcare companies, announces its exclusive licensing agreement with Pharmacosmos to commercialize and distribute Monofer®, an innovative intravenous iron replacement therapy for patients with a deficiency of this mineral. Through this strategic alliance, SteinCares strengthens its product portfolio in
